SIMCERE PHARMACEUTICAL GROUP Asset Impairment Charges
SIMCERE PHARMACEUTICAL GROUP reported Asset Impairment Charges of CNY 97.25 million for the 12-month period ending 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2013-04-26
CNY
| Period end | Asset Impairment Charges 12 month |
|---|---|
| 2012-12-31 | 97.25M CNY 20-F · filed 2013-04-26 |
USD
| Period end | Asset Impairment Charges 12 month |
|---|---|
| 2012-12-31 | $15.61M 20-F · filed 2013-04-26 |